A New "Non-Traditional" Antibacterial Drug Fluorothiazinone-Clinical Research in Patients with Complicated Urinary Tract Infections.
Antibiotics (Basel, Switzerland) • Vol. 13, Issue 6 • 2024
Fluorothiazinon inhibits the virulence factors of uropathogenic Escherichia coli involved in the development of urinary tract infection.
The Journal of antibiotics • Vol. 76, Issue 5 • 2023
Preventative treatment with Fluorothiazinon suppressed Acinetobacter baumannii-associated septicemia in mice.
The Journal of antibiotics • Vol. 75, Issue 3 • 2022
Assembly, structure, function and regulation of type III secretion systems.
Nature reviews. Microbiology • Vol. 15, Issue 6 • 2017